- ►ohsu.tv [PDF] CW Shults, D Oakes, K Kieburtz, MF Beal, R … - Archives of Neurology, 2002 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 468 - Related articles - BL Direct - All 17 versions
- ►onlinejacc.org H Krum, JJ McMurray - Journal of the American College of Cardiology, 2002 - Elsevier Hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins) are of proven
clinical benefit in coronary heart disease, at least in those patients who do
not have overt chronic heart failure (CHF). However, as there have been no ... Cited by 126 - Related articles - BL Direct - All 5 versions
- ►onlinejacc.org KKA Witte, AL Clark, JGF Cleland - Journal of the American College of Cardiology, 2001 - Elsevier Heart failure (HF) is associated with weight loss, and cachexia is a
well-recognized complication. Patients have an increased risk of osteoporosis
and lose muscle bulk early in the course of the disease. Basal metabolic ... Cited by 98 - Related articles - BL Direct - All 12 versions
- ►chestpubs.org S Mak, GE Newton - Chest, 2001 - chestjournal.chestpubs.org There is extensive experimental evidence from in vitro and animal experiments
that congestive heart failure (CHF) is a state of oxidative stress. Moreover, in
animal models, the development of CHF is accompanied by changes in the ... Cited by 77 - Related articles - BL Direct - All 6 versions
- ►oxfordjournals.org KKA Witte, NP Nikitin, AC Parker, S von … - European Heart Journal, 2005 - Eur Soc Cardiology Methods and results Thirty CHF patients [age 75.4 (0.7), mean (SEM), LV ejection
fraction (LVEF) 35%] were randomized to receive capsules containing a
combination of high-dose micronutrients (calcium, magnesium, zinc, copper, ... Cited by 75 - Related articles - All 7 versions
MT Tran, TM Mitchell, DT Kennedy, JT Giles - Pharmacotherapy, 2001 - PPI Mongthuong T. Tran, Pharm.D., Tina M. Mitchell, Pharm.D., Daniel T. Kennedy,
Pharm.D., and Joel T. Giles, Pharm.D. ... Purpose. Coenzyme Q10 (CoQ10) has a
pathophysiologic role in many disease states. The purpose of this review is ... Cited by 57 - Related articles - BL Direct - All 4 versions
F Rosenfeldt, D Hilton, S Pepe, H Krum - Biofactors, 2003 - IOS Press Abstract. Coenzyme Q10 in physical exercise. We identified eleven studies in
which CoQ10 was tested for an effect on exercise capacity, six showed a modest
improvement in exercise capacity with CoQ10 supplementation but five showed ... Cited by 52 - Related articles - BL Direct - All 5 versions
B Sarter - Journal of Cardiovascular Nursing, 2002 - journals.lww.com Coenzyme Q10 is an obligatory member of the respiratory chain in the mitochon-
dria of all cells. Therefore, it is an essential ingredient in the formation of
adenosine triphosphate (ATP), the source of energy in most cellular ... Cited by 48 - Related articles - BL Direct - All 4 versions
SA Mortensen - Biofactors, 2003 - IOS Press Abstract. Energy starvation of the myocardium is probably a dominant feature of
heart failure and attention has been directed towards agents which may stabilize
myocardial metabolism and maintain adequate energy stores. A reduced ... Cited by 43 - Related articles - BL Direct - All 5 versions
RA Bonakdar, E Guarneri… - Am Fam Physician, 2005 - aafp.org Coenzyme Q10 is a vitamin-like substance used in the treatment of a variety of
disorders primarily related to suboptimal cellular energy metabolism and
oxidative injury. Studies supporting the efficacy of coenzyme Q10 appear ... Cited by 46 - Related articles - All 13 versions
